Ok so a few contacts have done ok with Sareum (LON:SAR) shares over the last few days, it was only brought to my attention properly today and think i may of missed the main growth with this one, its a Cancer Research company that has had positive news about where the company is heading, the SP has literally tripled in a very short time due this news. It has come down somewhat and if the SP continues to come down then i may buy in to this.
Whats your views on this Stock?
There's some colour here - http://www.guardian.co.uk/business/marketforceslive/2011/mar/04/sareum-soars-cancer-inhibitor
it's just a pre-clinical trial, it's not like there's any sign of a licensing agreement... It is still very early stage - it might be worth a fortune or potentially nothing depending on years of newsflow to follow. Speculative biotech isn't for the faint hearted.
How would one go about valuing a company like this?